PMID: 9546935Jan 1, 1996Paper

Felodipine inhibits intimal lesion formation in the hypercholesterolemic rabbit: differential effects on endothelial and monocyte determinants of atherogenesis

Vascular Medicine
B Y WangJ P Cooke

Abstract

The purpose of this study was to determine if the calcium entry antagonist felodipine inhibited intimal lesion formation in hypercholesterolemic rabbits, and to determine if this was due to an effect upon monocyte and/or endothelial determinants of this interaction. Twenty-three male New Zealand White rabbits received the following treatment regimen for 10 weeks: normal chow (NP, n = 3); normal chow with felodipine infusion (NF, n = 6); 0.5% cholesterol chow (CP, n = 7); or 0.5% cholesterol chow and felodipine infusion (CF, n = 7). After 10 weeks blood was collected for biochemical measurements and mononuclear cell binding assays, and thoracic aortae were harvested for vascular reactivity studies and histomorphometry. In the animals receiving normal chow, felodipine did not significantly affect blood pressure, plasma cholesterol levels, binding studies, vascular reactivity, or structure; therefore these animals were analyzed as one group (N). Plasma cholesterol levels were significantly elevated in groups receiving the 0.5% cholesterol diet (N, 29 +/- 3 mg/dl; CP, 1221 +/- 73 mg/dl; CF, 979 +/- 108 mg/dl). High-density lipoprotein cholesterol was not different between the groups (25 +/- 4 vs 23 +/- 4 vs 27 +/- 4 mg/dl; N vs CF ...Continue Reading

References

Jan 1, 1992·Journal of Cardiovascular Pharmacology·P PaulettoC Dal Palù
May 1, 1992·European Journal of Epidemiology·S JostP Lichtlen
Sep 1, 1992·The Journal of Clinical Investigation·J P CookeM E Billingham
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S D CushingA M Fogelman
Mar 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·P M BathJ F Martin
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S Ylä-HerttualaD Steinberg
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·G SchmitzR Niemann
Feb 1, 1989·The Journal of Clinical Investigation·J A OsborneA M Lefer
Oct 1, 1988·The Journal of Pathology·L ManwarringA J Dobson
Dec 1, 1987·The Journal of Clinical Investigation·D G HarrisonD D Heistad
Jan 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·O SteinY Stein
May 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A L WillisD L Puppione
Jun 1, 1983·Journal of the American College of Cardiology·J L RouleauR J Havel
Nov 1, 1981·The Journal of Clinical Investigation·P D Henry, K I Bentley
Jun 9, 1995·The Journal of Biological Chemistry·H B PengJ K Liao
Mar 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J A KimJ A Berliner
Feb 1, 1994·Journal of the American College of Cardiology·B Y WangJ P Cooke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.